Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 35.37 USD -4.22% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
Verona Pharma PLC?
Write Note

Verona Pharma PLC
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Verona Pharma PLC
Cash Interest Paid Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
Verona Pharma PLC
NASDAQ:VRNA
Cash Interest Paid
$7.2m
CAGR 3-Years
249%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Cash Interest Paid
ÂŁ660m
CAGR 3-Years
-7%
CAGR 5-Years
-5%
CAGR 10-Years
-1%
AstraZeneca PLC
LSE:AZN
Cash Interest Paid
$1.2B
CAGR 3-Years
18%
CAGR 5-Years
9%
CAGR 10-Years
9%
Indivior PLC
LSE:INDV
Cash Interest Paid
$32m
CAGR 3-Years
15%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Cash Interest Paid
$81m
CAGR 3-Years
27%
CAGR 5-Years
9%
CAGR 10-Years
9%
Dechra Pharmaceuticals PLC
LSE:DPH
Cash Interest Paid
ÂŁ18.3m
CAGR 3-Years
31%
CAGR 5-Years
26%
CAGR 10-Years
14%

See Also

What is Verona Pharma PLC's Cash Interest Paid?
Cash Interest Paid
7.2m USD

Based on the financial report for Sep 30, 2024, Verona Pharma PLC's Cash Interest Paid amounts to 7.2m USD.

What is Verona Pharma PLC's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 3Y
249%

Over the last year, the Cash Interest Paid growth was 421%. The average annual Cash Interest Paid growth rates for Verona Pharma PLC have been 249% over the past three years .

Back to Top